NEWS & PRESS RELEASES
ENEA Tech e Biomedical and InnovHeart clinical development of Saturn TMVR system
Watch this video to learn more about the vision behind the Saturn TMVR from CEO David Wilson, Founder and CTO Giovanni Righini, and VP Quality Daniele Marziantonio. We are grateful to ENEA Tech e Biomedical for helping drive the clinical development of Saturn TMVR...
First Patient Results Published in JACC Case Reports
JACC Case Reports published the first report of a patient with the SATURN Trans-septal System in the CASSINI EU Early Feasibility Study. A 66-year-old woman with 3+ symptomatic MR patient underwent treatment with the fully percutaneous, transfemoral, transseptal...
First-In-Human Trans-Septal Implantation of Saturn Mitral Valve Replacement
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”
William Pollard